-
Novartis' Entresto faces first US generic competitors
06 Aug 2025 04:53 GMT
-
Novartis sues Oregon over new law on discounted drug access
04 Aug 2025 20:17 GMT
… flexibility.
But in 2020, Novartis and other drugmakers began placing … in Oregon federal court, Novartis argues the state has overstepped … data to prevent fraud. Novartis claims Oregon’s new law … what federal rules require.
Novartis and other drug companies have …
-
Altos Labs hires a new medical chief with mTOR experience, Novartis chops
04 Aug 2025 20:14 GMT
-
Entresto Trade Dress Dispute: No Injunctive Relief for Novartis
04 Aug 2025 18:28 GMT
… District of New Jersey denied Novartis’s motion for preliminary … in the pharmaceutical context.
Novartis’s trade dress case is … generic version of Entresto, Novartis’s blockbuster drug that has … an injunction in place, Novartis’s trade dress allegations cannot …
-
Novartis is helping patients ‘SMAsh’ their limits with advocacy campaign
04 Aug 2025 08:27 GMT
… teens and young adults.
Novartis has stepped up for those … area head of neuroscience at Novartis.
The drugmaker’s market … treatment options.
Dawson says Novartis has been working closely with … says Dawson.
That insight led Novartis to craft a support system …
-
Novartis Told to Revise Protocol, Justify Sample Size in ITU512 Clinical Trial Proposal
03 Aug 2025 05:01 GMT
… at CDSCO headquarters, New Delhi. Novartis presented Protocol No.CITU512A12101, Version …
-
FDA Approves Label Update for Novartis’ Leqvio to Enable Twice-Yearly Monotherapy for LDL-C Management in Adults with Hypercholesterolemia
01 Aug 2025 22:22 GMT
… site reaction, arthralgia, and bronchitis. Novartis warns that Leqvio is contraindicated … and Corporate Strategy
According to Novartis, ASCVD accounts for approximately 85% … .html
HIGHLIGHTS OF PRESCRIBING INFORMATION. Novartis. Accessed August 1, 2025. https …
-
US sets deadline for Novartis and other pharma firms to lower prices
01 Aug 2025 16:05 GMT
… asking for price drops, said Novartis.
Keystone / Gaetan … companies – including Swiss giant Novartis – calling for immediate measures … currently reviewing the letter,” Novartis wrote in response to … Oddo BHF estimates that Novartis, which is heavily …
-
Behcet's Disease Market Analysis and Forecast, 2025-2035 | AbbVie, Novartis, F. Hoffmann-La Roche, J&J, and BMS Advance Biologics and Immunomodulatory Therapies to Transform the Landscape - ResearchAndMarkets.com
01 Aug 2025 12:29 GMT
… companies such as AbbVie Inc., Novartis AG, F. Hoffmann-La Roche … Analyst View
5.2.8 Novartis AG
5.2.8.1 …
F. Hoffmann-La Roche Ltd
Novartis AG
GlaxoSmithKline plc
Sanguine Biosciences …
-
American Kidney Fund Expands 'Me + C3G' Campaign With New Resources To Help Patients Living With This Rare Kidney Disease
06 Aug 2025 14:12 GMT
… with financial support from Novartis Pharmaceuticals Corporation (Novartis), these resources expand the … CEO.“We are grateful to Novartis for continuing to support this …